Transcriptional control of apolipoprotein A-I gene expression in diabetes.

  title={Transcriptional control of apolipoprotein A-I gene expression in diabetes.},
  author={Arshag D Mooradian and Michael J. Haas and Norman C. W. Wong},
  volume={53 3},
Cardiovascular disease continues to be the leading cause of mortality in diabetes. One of the factors contributing to the increased risk is the high prevalence rate of low plasma concentrations of HDL cholesterol. Multiple potential mechanisms account for the cardioprotective effects of HDL and its main protein apolipoprotein (apo) A-I. The reduced plasma concentrations of HDL could be the result of increased fractional clearance of HDL and reduced expression of apo A-I. In animal models of… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
32 Citations
69 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 32 extracted citations


Publications referenced by this paper.
Showing 1-10 of 69 references

High-density lipoprotein metabolism: molecular targets for new therapies for atherosclerosis

  • M Kawahiri, C Maugeais, D Rader
  • Curr Atheroscler Rep 2:363–372,
  • 2000
Highly Influential
6 Excerpts

Suppression of apoli- poprotein A-I gene expression in HepG2 cells by TNF and IL 1

  • MJ Haas, MH Horani, CNW Wong, AD Mooradian
  • Biochim Biophys Acta 1623:120–128,
  • 2003
Highly Influential
3 Excerpts

Haas, and N.c.w

  • MJ Franz, JP Bantle, +9 authors MOORADIAN M.J.A.D
  • 2004
2 Excerpts

Stimulation of fecal FIG. 3. A schematic summary of the myriad of changes that occur in diabetes, culminating in reduced plasma apo A-I concentrations. APOLIPOPROTEIN A-I IN DIABETES 518 DIABETES

  • M Eriksson, LA Carlson, TA Miettinen, B Angelin
  • VOL. 53,
  • 2004

Similar Papers

Loading similar papers…